NCT04967157

Cognitive Effects of Citicoline on Attention in Healthy Mean and Women

A Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Assess the Cognitive Effects of a Citicoline Supplement (Cognizin®) on Attention in Healthy Men and Women

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 148 (actual)
• Sponsor: Kirin Holdings Company, Limited · Industry
• Sex: All
• Age: 35 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The objective of this trial is to determine the effects of citicoline on cognitive performance for attention in healrhy Men and Women compared to a placebo.

Detailed description

This study is a 12-week, randomized, double-blind, placebo-controlled trial of citicoline in healthy men and women. Cognitive assessments will be performed to determine whether citicoline administration improves attention, compared to placebo administration. \*\*Note: This note is to inform you that the Unique Protocol ID BIO-2104 was unintentionally combined with another Unique Protocol ID, K5-24-01-T0060, resulting in history records that should not be considered as part of the BIO-2104's timeline. This explanation has been added per PRS instructions to ensure compliance and maintain data integrity in alignment with the protocol.

Conditions

• Healthy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Placebo supplement	Cellulose
DIETARY_SUPPLEMENT	Citicoline supplement	Cognizin ®

Timeline

• Start date: 2021-09-08
• Primary completion: 2022-08-31
• Completion: 2022-08-31
• First posted: 2021-07-19
• Last updated: 2025-04-06

Locations

1 site across 1 country: United States